Kori Kaufman

Contracts Manager

Albany Molecular Research, Inc. (AMRI) (now Curia Global, Inc.)

• Responsible for agreements involving outsourced drug discovery and commercial manufacture of API
• Worked with AMRI’s international subsidiaries on corporate governance and compliance
• While a member of AMRI’s business development group, focused on proposal drafting and review, marketing and submissions for governmental contracts

Kori completed doctorate level course work in Anthropology at the University at Albany, State University of New York.

• Supported numerous Phase 1 through 3 oncology clinical trials of multiple small molecules sponsored by Deciphera Pharmaceuticals, LLC (a member of Ono Pharma), including coordinating, drafting and negotiating clinical trial agreements, clinical service agreements, informed consents, and related agreements for multinational trials involving sites in North America, Europe, South America, Asia, and Australia
• Supported CG Pharmaceuticals, Inc. in a Phase 1b/2 clinical trial of their novel HDAC inhibitor targeting metastatic pancreatic adenocarcinoma involving approximately 20 sites in the United States
• Assisted publicly-traded biotech client with US clinical trials at multiple dialysis centers focusing on additional indications of approved nephrology product
• Assisted multiple clients in obtaining and reviewing advice from local and privacy counsel for clinical trial related agreements in Europe, Asia, and Latin America
• Drafted and negotiated service agreements with service providers for clinical and preclinical studies, of therapeutic and medical device products, including start-up and master services agreements valued at over $500,000 with large, multinational contract research organizations

Kori presented at MCLE’s 25^th Annual Paralegal Conference on the role of contract management in the pharmaceutical and biotech industry.